Literature DB >> 10644663

Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine.

C I Cruz1, P Ruiz-Torres, R G del Moral, M Rodríguez-Puyol, D Rodríguez-Puyol.   

Abstract

Our previous studies demonstrated an increased reactive oxygen species (ROS) production, as well as transforming growth factor-beta1 (TGF-beta1) expression in the rat kidney with aging. In the present study, we examined the effect of aging on extracellular matrix (ECM) accumulation and the effects of treatment with angiotensin-converting enzyme inhibitors (captopril and lisinopril) and taurine, an antioxidant amino acid. Age-related increases in types I and IV collagen and fibronectin mRNA expression were found at 24 and 30 mo of age. In contrast, type III collagen only increased in 30-mo-old rats. Captopril-, lisinopril-, and taurine-treated animals showed a statistically significant decrease in ECM protein expression at both ages. Moreover, treatment with taurine reduced the TGF-beta1 mRNA levels in 24- and 30-mo-old rats by 40%. Taurine also completely blocked increases in type I and type IV collagen expression in mesangial cells in response to TGF-beta1. Our results demonstrate a protective role from both converting enzyme inhibitors and taurine in the age-related progressive renal sclerosis. In addition, taking into account that taurine is considered as an antioxidant amino acid, present data suggest a role for ROS in age-related progressive renal fibrosis, perhaps through interactions with the TGF-beta1 pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644663     DOI: 10.1152/ajprenal.2000.278.1.F122

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  20 in total

1.  The Effect of Perinatal Taurine on Adult Renal Function Does Not Appear to Be Mediated by Taurine's Inhibition of the Renin-Angiotensin System.

Authors:  Sanya Roysommuti; Angkana Kritsongsakchai; J Michael Wyss
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 2.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 3.  Kidney aging--inevitable or preventable?

Authors:  Devasmita Choudhury; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

4.  Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.

Authors:  J Ruth Wu-Wong; Yung-Wu Chen; Jerry L Wessale
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-10

5.  Perinatal taurine alters arterial pressure control and renal function in adult offspring.

Authors:  Sanya Roysommuti; Wichaporn Lerdweeraphon; Pisamai Malila; Dusit Jirakulsomchok; J Michael Wyss
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

6.  The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease.

Authors:  Petra Zürbig; Stéphane Decramer; Mohammed Dakna; Justyna Jantos; David M Good; Joshua J Coon; Flavio Bandin; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

Review 7.  Perinatal taurine exposure affects adult arterial pressure control.

Authors:  Sanya Roysommuti; J Michael Wyss
Journal:  Amino Acids       Date:  2012-10-16       Impact factor: 3.520

8.  Age-related differences in adriamycin-induced nephropathy.

Authors:  Hyewon Hahn; Young Seo Park; Il Soo Ha; Hae Il Cheong; Yong Choi
Journal:  Pediatr Nephrol       Date:  2004-05-11       Impact factor: 3.714

9.  Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure.

Authors:  Utpal Sen; Poulami Basu; Oluwasegun A Abe; Srikanth Givvimani; Neetu Tyagi; Naira Metreveli; Karan S Shah; John C Passmore; Suresh C Tyagi
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-27

Review 10.  Renal Aging: Causes and Consequences.

Authors:  Eoin D O'Sullivan; Jeremy Hughes; David A Ferenbach
Journal:  J Am Soc Nephrol       Date:  2016-11-15       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.